Personalizing the care and treatment of Alzheimer's disease: an overview

D Svob Strac, M Konjevod, M Sagud… - Pharmacogenomics …, 2021 - Taylor & Francis
Alzheimer's disease (AD) is a progressive, complex, and multifactorial neurodegenerative
disorder, still without effective and stable therapeutic strategies. Currently, available …

A review of frequently used Kampo prescriptions. Part 3. Yokukansan

H Yamaguchi, T Yoshino, H Oizumi… - Traditional & Kampo …, 2023 - Wiley Online Library
Background The source of yokukansan (YKS) is thought to be Baoying‐Jinjiang
(Hoeikinkyōroku in Japanese) by Xue Ji. YKS was originally designed for children and …

[HTML][HTML] Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties …

T Wichur, A Pasieka, J Godyń, D Panek, I Góral… - European Journal of …, 2021 - Elsevier
Multifunctional ligands as an essential variant of polypharmacology are promising
candidates for the treatment of multi-factorial diseases like Alzheimer's disease. Based on …

[HTML][HTML] Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease

C Flores-Clemente, MI Nicolás-Vázquez… - Biomolecules, 2021 - mdpi.com
Alzheimer's disease (AD) represents the principal cause of dementia among the elderly.
Great efforts have been established to understand the physiopathology of AD. Changes in …

[HTML][HTML] Brain mitochondrial dysfunction: a possible mechanism links early life anxiety to alzheimer's disease in later life

Q Wang, M Lu, X Zhu, X Gu, T Zhang, C Xia… - Aging and …, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) is usually manifested in patients with dementia, accompanied by
anxiety and other mental symptoms. Emerging evidence from humans indicates that people …

[HTML][HTML] Genetically predicted circulating levels of glycine, glutamate, and serotonin in relation to the risks of three major neurodegenerative diseases: A Mendelian …

R Li, M Deng, Y Lin, W Gao, B Liu… - Frontiers in Aging …, 2022 - frontiersin.org
It has been previously postulated that blood neurotransmitters might affect risks of
neurodegenerative diseases. Here, a Mendelian Randomization (MR) study was conducted …

Effects of olfactory stimulation on cognitive function and behavior problems in older adults with dementia: A systematic literature review

H Cha, S Kim, M Seo, H Kim - Geriatric Nursing, 2021 - Elsevier
The aim of this study was to examine the effects of olfactory stimulation on both cognitive
and behavioral symptoms in neurodegenerative diseases. The criteria for selection of …

Neuropsychiatric symptoms of Alzheimer's disease: An anatomic-genetic framework for treatment development

MA Nowrangi, JD Outen, J Kim… - Journal of …, 2023 - content.iospress.com
Background: Despite the burden on patients and caregivers, there are no approved
therapies for the neuropsychiatric symptoms of Alzheimer's disease (NPS-AD). This is likely …

Future directions in molecular imaging of neurodegenerative disorders

H Barthel, VL Villemagne… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The improvement of existing techniques and the development of new molecular imaging
methods are an exciting and rapidly developing field in clinical care and research of …

Biological and pharmacological characterization of ascorbic acid and nicotinamide chitosan nanoparticles against insulin-resistance-induced cognitive defects: a …

H Abd-Allah, M Nasr, OAH Ahmed-Farid… - ACS …, 2021 - ACS Publications
High consumption of industrialized food with high fat content is generally associated with
insulin resistance, which in turn causes memory impairment and cognitive decline …